Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: Scott H. Davis who wrote (2709)	9/29/1999 12:03:00 PM
From: Greg Rich	Read Replies (1) \| Respond to of 4676

Scott: I have been reading many of your posts for some time (especially in the VICL and ISIP threads) and seem to share your perspective on a lot of what is happening (and hopefully about to happen) in the biotech sector. I know that no one here can or should be telling anyone else what to do about their investing decisions, but... If you wouldn't mind giving an opinion on the following matter, I would appreciate your ideas. I have had a very good ride thus far with Imclone Systems. My sense is that IMCL has topped out for a little while and I am thinking of selling part of my position (a substantial one for me) and loading up on either more ISIP or VICL, as I see both as having more short-term upside potential within the next six to nine months. It seems you follow both companies closely. Do you have an opinion on which has a better chance of a significant upside move in the next six to twelve months? Thanks in advance, greg